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Background: Endothelial cell (EC) apoptosis plays an important role in atherosclerosis initiation and plaque stability. Thrombomodulin (TM) is an 
EC-bound anticoagulation protein. Soluble TM was found in circulating plasma; however, its physiological significance was unknown. We examined 
the effect of soluble TM on vascular EC apoptosis and its related mechanisms. 
Methods and Results: Data were expressed as mean±SD. Cultured human umbilical vein ECs were stressed with serum starvation (SS, 0.5% 
fetal bovine serum) and EC apoptosis was determined by TUNEL assay and DNA fragmentation assay using Cell Death Detection ELISA kit. ECs 
were pretreated with recombinant TM protein or saline and apoptosis was induced by SS. There was a dose-dependent reduction of apoptosis in 
TM-treated ECs both in TUNEL assay (saline vs 10 vs 30 vs 50 ng/mL TM, apoptotic cell number ratio: 1 vs 0.44±0.06 vs 0.22±0.04 vs 0.08±0.01, 
p<0.01) and Cell Death Detection ELISA (saline vs 10 vs 30 vs 50 ng/mL TM, apoptosis ratio: 1 vs 0.90±0.17 vs 0.53±0.11 vs 0.51±0.18, p<0.01). 
The anti-apoptotic effect of TM was blocked by PI3 kinase inhibitors wortmannin and LY 294002. Akt phosphorylation (phos) was suppressed after 
SS and TM treatment could restore the Akt phos at 24 hrs after SS (0 vs 2 vs 4 vs 6 vs 16 vs 24 hrs after SS and 50 ng/mL TM, Akt pho ratio: 1 vs 
0.92±0.53 vs 1.05±0.55 vs 0.96±0.24 vs 1.43±0.42 vs 1.48±0.66, p<0.05). SS induced c-Jun NH2-terminal kinase (JNK) phos and TM treatment 
could suppressed JNK phos at 24 hrs after SS (0 vs 2 vs 4 vs 6 vs 16 vs 24 hrs after SS and 50 ng/mL TM, JNK pho ratio: 1 vs 0.72±0.08 vs 
2.72±0.86 vs 3.77±0.89 vs 1.69±0.70 vs 0.94±0.06, p<0.01). 
Conclusions: Soluble TM is a cytoprotective factor that reduces EC apoptosis. There is a novel therapeutic potential of TM in endothelial 
dysfunction.
